113.62  -0.44 (-0.39%)		08-28 16:00
Open: 113.59 High: 113.985 Volume: 272,067		Pre. Close: 114.06 Low: 113.153 Market Cap: 987(M)

Short term
Mid term
Targets	6-month :	137.81	1-year :	160.96
Resists	First :	117.98	Second :	137.81
Pivot price	113.98
Supports	First :	111.63	Second :	107.69
MAs	MA(5) :	115.58	MA(20) :	112.9
	MA(100) :	106.45	MA(250) :	101.64
MACD	MACD :	1.5	Signal :	1.5
%K %D	K(14,3) :	57.5	D(3) :	73.1
RSI	RSI(14): 52.5
52-week	High :	117.98	Low :	84.1

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ PPH ] has closed above bottom band by 46.1%. Bollinger Bands are 37.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	114.11 - 115.04	115.04 - 115.66
Low:	111.19 - 112.23	112.23 - 112.93
Close:	112.26 - 113.87	113.87 - 114.95

VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Thu, 27 Aug 2026
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now - TradingView

Wed, 26 Aug 2026
Fidelity vs VanEck Healthcare ETFs: Broad Exposure or Pharma Focus - The Motley Fool

Tue, 18 Aug 2026
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool

Wed, 12 Aug 2026
VanEck Pharmaceutical ETF vs. Invesco Biotech ETF: Which Fund Fits Your Investing Style? - The Motley Fool

Wed, 05 Aug 2026
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? - Yahoo Finance

Fri, 17 Jul 2026
Use These ETFs as Health Stocks LLY, UNH, MRK Thrive - ETF Database

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.